Chemed Corporation $CHE Shares Sold by Fort Washington Investment Advisors Inc. OH

Key Points

• Fort Washington Investment Advisors Inc. has reduced its stake in Chemed Corporation by 3.4%, now owning approximately 38,392 shares valued at $18.7 million.
• Several hedge funds have increased their investments in Chemed, with Ausbil Investment Management raising its holdings by 345.5% during the second quarter.
• Chemed recently increased its quarterly dividend from $0.50 to $0.60, representing a yield of 0.5%, and set its FY 2025 earnings guidance at $22.00 to $22.30 per share.

Fort Washington Investment Advisors Inc. OH cut its stake in shares of Chemed Corporation (NYSE:CHE - Free Report) by 3.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,392 shares of the company's stock after selling 1,363 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned about 0.26% of Chemed worth $18,694,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CHE. Ausbil Investment Management Ltd increased its holdings in Chemed by 345.5% in the 2nd quarter. Ausbil Investment Management Ltd now owns 2,753 shares of the company's stock worth $1,341,000 after buying an additional 2,135 shares during the period. Formidable Asset Management LLC raised its holdings in shares of Chemed by 0.9% during the second quarter. Formidable Asset Management LLC now owns 20,266 shares of the company's stock worth $9,868,000 after purchasing an additional 179 shares during the last quarter. One Plus One Wealth Management LLC lifted its position in Chemed by 4.3% during the second quarter. One Plus One Wealth Management LLC now owns 867 shares of the company's stock valued at $422,000 after purchasing an additional 36 shares during the period. MBE Wealth Management LLC boosted its holdings in Chemed by 9.0% in the second quarter. MBE Wealth Management LLC now owns 592 shares of the company's stock valued at $288,000 after purchasing an additional 49 shares during the last quarter. Finally, Fortune Financial Advisors LLC grew its position in Chemed by 47.7% during the 2nd quarter. Fortune Financial Advisors LLC now owns 1,603 shares of the company's stock worth $781,000 after purchasing an additional 518 shares during the period. Hedge funds and other institutional investors own 95.85% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on CHE shares. Bank of America lowered their target price on Chemed from $610.00 to $595.00 and set a "buy" rating on the stock in a research note on Wednesday, September 10th. Oppenheimer lowered their price objective on Chemed from $650.00 to $580.00 and set an "outperform" rating on the stock in a research report on Thursday, July 31st. Royal Bank Of Canada dropped their price objective on shares of Chemed from $640.00 to $589.00 and set an "outperform" rating on the stock in a research note on Thursday, July 31st. Jefferies Financial Group upgraded shares of Chemed from a "hold" rating to a "buy" rating and boosted their target price for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Finally, Wall Street Zen lowered shares of Chemed from a "buy" rating to a "hold" rating in a research report on Saturday, July 5th. Four analysts have rated the stock with a Buy rating, According to MarketBeat.com, Chemed currently has an average rating of "Buy" and an average target price of $578.50.

Insider Buying and Selling at Chemed

In other Chemed news, Director George J. Walsh III bought 200 shares of Chemed stock in a transaction dated Monday, August 4th. The stock was acquired at an average cost of $417.10 per share, for a total transaction of $83,420.00. Following the completion of the transaction, the director directly owned 3,523 shares of the company's stock, valued at approximately $1,469,443.30. This represents a 6.02% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Patrick P. Grace sold 150 shares of the firm's stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $463.39, for a total transaction of $69,508.50. Following the completion of the transaction, the director directly owned 3,397 shares in the company, valued at approximately $1,574,135.83. This represents a 4.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.29% of the stock is currently owned by insiders.

Chemed Stock Up 2.6%

CHE stock opened at $462.30 on Monday. Chemed Corporation has a 52 week low of $408.42 and a 52 week high of $623.60. The firm has a 50-day simple moving average of $450.29 and a 200-day simple moving average of $520.75. The stock has a market capitalization of $6.74 billion, a P/E ratio of 23.77, a P/E/G ratio of 2.69 and a beta of 0.46.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $4.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.02 by ($1.75). Chemed had a net margin of 11.56% and a return on equity of 25.83%. The company had revenue of $618.80 million during the quarter, compared to analysts' expectations of $650.60 million. During the same period in the prior year, the business posted $5.47 earnings per share. The company's quarterly revenue was up 3.8% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, analysts expect that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 11th were paid a $0.60 dividend. The ex-dividend date of this dividend was Monday, August 11th. This represents a $2.40 annualized dividend and a yield of 0.5%. This is an increase from Chemed's previous quarterly dividend of $0.50. Chemed's dividend payout ratio is currently 12.34%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.